Task: Answer the multiple-choice question.
Question: Which drug exhibits a 9.534\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) Cc1ccc(C(C)C)c(O)c1
b.) COc1ccc(NC(=O)NNC(=O)c2ccc(Cl)cc2Cl)cc1OC
c.) CC(C)Cn1c(SCC(=O)Nc2ncccn2)nc2ccccc21
d.) COC(=O)N/N=C/c1cc([N+](=O)[O-])cc(Br)c1O
Answer: c. CC(C)Cn1c(SCC(=O)Nc2ncccn2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
2-[1-(2-methylpropyl)benzimidazol-2-yl]sulfanyl-N-pyrimidin-2-ylacetamide